Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00503217
NCT00503217
Completed
Phase 4

Effect of GnRH Agonist Administration at the Time of Implantation in Intrauterine Insemination Cycles: A Randomized Controlled Trial

Instituto Valenciano de Infertilidad, IVI VALENCIA1 site in 1 countryFebruary 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIntrauterine Insemination
DrugsTryptorelin

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Intrauterine Insemination
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Locations
1
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.

Registry
clinicaltrials.gov
Start Date
February 2005
End Date
December 2007
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Responsible Party
Principal Investigator
Principal Investigator

Jose Bellver

Gynecologist IVI Valencia

Instituto Valenciano de Infertilidad, IVI VALENCIA

Eligibility Criteria

Inclusion Criteria

  • •Women \< 38 years old
  • •Bilateral tubal patency confirmed by hysterosonography
  • •Normal ultrasound scan of uterus and ovaries
  • •Normal day 3 basal hormones
  • •Motile sperm count after capacitation ≥ 3 mill/ml

Exclusion Criteria

  • •Endometriosis
  • •Polycystic ovary syndrome
  • •Uterine disease (polyps, myomas and müllerian diseases)

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 3
The effect of decapeptile on treatment of infertile women in ICSI(Intracytoplasmic Sperm Injection) cyclesInfertility.Female infertility, unspecified
IRCT2012111111430N1Reaserch center of Avicenna100
Completed
Phase 3
GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCTInfertility
NCT03039049Centre Hospitalier Universitaire Ibn Rochd328
Completed
Phase 2
Effects of GnRH agonist for luteal phase supportfemale infertility.Female infertility
IRCT20110509006420N20Yazd University of Medical Sciences200
Unknown
Phase 1
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer CyclesGnRHa;LPS
NCT02908438Northwest Women's and Children's Hospital, Xi'an, Shaanxi400
Terminated
Phase 3
Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET CyclesInfertility
NCT01007851V.K.V. American Hospital, Istanbul